Impact of lifestyle intervention in primary prevention of Type 2 diabetes did not differ by baseline age and BMI among Asian-Indian people with impaired glucose tolerance

Diabetic Medicine

Volumn 33, Issue 12, 2016, Pages 1700-1704

  Nanditha, A ^a,b   Snehalatha, C ^a,b   Ram, J ^a   Selvam, S ^a   Vijaya, L ^a   Shetty, S A ^a,b   Arun, R ^a,b   Ramachandran, A ^a,b  

^a India Diabetes Research Foundation   (India)

^b Dr A Ramachandran's Diabetes Hospitals   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; METFORMIN;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETIC OBESITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENTAL FINDING; INDIAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; SECONDARY ANALYSIS; ASIA; ETHNOLOGY; GLUCOSE INTOLERANCE; HEALTHY LIFESTYLE; INDIA; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ASIA; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HEALTHY LIFESTYLE; HUMANS; INDIA; MALE; MIDDLE AGED; PREDIABETIC STATE; PRIMARY PREVENTION; PROSPECTIVE STUDIES;

EID: 84959147561     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13071     Document Type: Article

References (21)

1. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007; 334: 299.
2. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–1350.
3. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.
4. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006; 49: 289–297.
5. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537–544.
6. Ramachandran A, Snehalatha C, Ram J, Selvam S, Mary S, Nanditha A et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 2013; 1: 191–198.
7. Report of the Expert Committee on the Diagnosis, Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–1197.
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
9. Ram J, Snehalatha C, Selvam S, Nanditha A, Shetty A, Godsland I et al. The oral disposition index is a strong predictor of incident diabetes in Asian Indian prediabetic men. Acta Diabetologica 2015: 1–9.
10. Report of the WHO consultation, “Obesity preventing and managing the global epidemic” World Health Organization – Technical Report Series. No. 891. Geneva: WHO, 2000; 1–253.
11. Irwig L, Irwig J, Trevena L, Sweet M. Smart Health Choices: Making Sense of Health Advice. Chapter 18, Relative risk, relative and absolute risk reduction, number needed to treat and confidence intervals. London: Hammersmith Press, 2008. Available at http://www.ncbi.nlm.nih.gov/books/NBK63647/.
12. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003; 326: 219.
13. Altman DG, Matthews JN. Statistics notes. Interaction 1: Heterogeneity of effects. BMJ 1996; 313: 486.
14. Lindstrom J, Peltonen M, Eriksson JG, Aunola S, Hamalainen H, Ilanne-Parikka P et al. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care 2008; 31: 857–862.
15. Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006; 29: 2102–2107.
16. Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001; 86: 5366–5371.
17. Ramachandran A, Snehalatha C, Samith A, Shetty SA, Arun N, Susairaj P. Obesity in Asia–is it different from the rest of the world. Diabetes Metab Res Rev 2012; 28: 47–51.
18. Ramachandran A, Snehalatha C, Vijay V. Low risk threshold for acquired diabetogenic factors in Asian Indians. Diabetes Res Clin Pract 2004; 65: 189–195.
19. The DECODE-DECODA study Group. Age, body mass index and type 2 diabetes-associations modified by ethnicity. Diabetologia 2003; 46: 1063–1070.
20. Ntuk UE, Gill JM, Mackay DF, Sattar N, Pell JP. Ethnic-Specific Obesity Cutoffs for Diabetes Risk: Cross-sectional Study of 490,288 UK Biobank Participants. Diabetes Care 2014; 37: 2500–2507.
21. Barte JC, Veldwijk J, Teixeira PJ, Sacks FM, Bemelmans WJ. Differences in weight loss across different BMI classes: a meta-analysis of the effects of interventions with diet and exercise. Int J Behav Med 2014; 21: 784–793.